Capricorn resignations a blow to New Med merger plans
The disputed deal is playing out in public, as Capricorn’s board and activist shareholder Palliser both issue statements and rebuttals
The proposed merger of London-listed Capricorn Energy and Israel’s Newmed may have been scuppered by shareholder opposition. Five of the Capricorn board’s nine members resigned in late January, including the chairman and CEO. Another two board members, including the CFO, have committed to resign before 1 February. That is when shareholders will meet—as requested by shareholder and London-based fund Palliser Capital—to approve replacement board members, instead of voting on the merger deal, as was previously scheduled. The merger vote itself has now been pushed back to 22 February, which Capricorn says will allow “a reconstituted board to assess the proposed Newmed combination alongside other

Also in this section
22 September 2023
Former executives and a successor company are accused of complicity in Sudanese war crimes in what is now South Sudan
21 September 2023
Nigeria’s downstream status quo changed forever with the end of fuel subsidies, but the flagship Dangote refinery has still yet to start operations
20 September 2023
Geographical position, long-term demand and decarbonisation efforts continue to support the region’s burgeoning LNG sector
19 September 2023
The special administrative region has introduced the fuel as part of its drive for carbon neutrality, but it will take years for imports to ramp up